Table 1.

General characteristics of the patients

	Cisplatin group (n=109)	Nedaplatin group (n=110)	P-value
Male, n (%)	60 (55.05)	54 (49.09)	0.378
Age (year)	52.05±11.53	51.95±11.48	0.953
Body mass index (kg/m2)	21.1±2.16	20.86±2.05	0.594
Diabetes, n (%)	7 (6.42)	11 (10.00)	0.335
Cardiovascular disease, n (%)	17 (15.60)	17 (15.45)	0.977
Pulmonary heart disease, n (%)	6 (0.06)	5 (0.045)	0.745

Note: Data presented as mean ± SD.